Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Dendritica AB
AB
Active
Org 5590876412
Staglabergsgatan 5
General medical practice activities · NACE 8621
Est. 2016
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 533K
-14% vs 2024
EBITDA margin
32.0%
-49% vs 2024
Equity ratio
48.4%
Financial strength
Net profit 2025
SEK 139K
-48% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 533K
-14%
EBITDA
SEK 171K
-49%
Net profit
SEK 139K
-48%
Total assets
SEK 538K
+12%
Equity
SEK 260K
-20%
Employees
0
—
Company information
Legal name
Dendritica AB
Org number
5590876412
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
29 november 2016
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-07-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultverksamhet inom hälso- och sjukvård samt handel med värdepapper och därmed förenlig verksamhet.
Contact
Address
Staglabergsgatan 5
Email
per.nilsson.81@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Växjö
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
1M
2023
1M
2024
1M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
434
463
509
622
533
Staff expenses
—
—
—
—
−286
EBITDA
259
279
191
334
171
Depreciation & amort.
−0
−0
−0
−0
—
EBIT
259
279
191
334
171
Net financials
10
−70
−27
4
4
Profit before tax
269
243
176
338
175
Tax
−55
−57
−39
−70
−36
Net profit
214
186
137
268
139
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
414
478
405
481
538
Equity
299
301
251
325
260
Long-term debt
0
0
0
0
—
Short-term debt
115
177
153
156
278
Total debt
115
177
153
156
278
Financial ratios
5-year trend
EBITDA margin
32.0%
This company
15.8%
Market median
+103% vs market
2021
2025
Equity ratio
48.4%
This company
38.2%
Market median
+27% vs market
2021
2025
Return on equity
53.5%
This company
18.4%
Market median
+191% vs market
2021
2025
Net profit margin
26.1%
This company
8.1%
Market median
+222% vs market
2021
2025
Asset turnover
0.99×
This company
1.12×
Market median
+12% vs market
2021
2025
Debt / equity
1.07×
This company
0.62×
Market median
-73% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-08-01 – 2025-07-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-08-01 – 2024-07-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-08-01 – 2023-07-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-08-01 – 2022-07-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-08-01 – 2021-07-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
YK
Ylva Kristina Karlman
Deputy Board Member
2022
PE
Per Erik Bengt Karlman
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Dendritica AB also hold positions in
0
other companies.
Person
Role here
Other companies
Ylva Kristina Karlman
Deputy Board Member
0 companies
Per Erik Bengt Karlman
Board of Directors
0 companies